Treprostinil
Brand name: Tyvaso Dpi
Rank #112 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$158.9M
Total Cost
6,704
Total Claims
$158.9M
Total Cost
187
Prescribers
$24K
Cost per Claim
354
Beneficiaries
6,711
30-Day Fills
$850K
Avg Cost/Provider
36
Avg Claims/Provider
Share of Medicare Part D Spending
0.06%
of total Medicare Part D spending
$158.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $158.9M total
🔎 Data Overview
At $23,703 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $849,772 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $448,891 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Treprostinil
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Vallerie Mclaughlin | Cardiology | Ann Arbor, MI | 406 | $9.5M |
| 2 | Eric Roberts | Advanced Heart Failure and Transplant Cardiology | Milwaukee, WI | 297 | $7.1M |
| 3 | Ashwin Ravichandran | Advanced Heart Failure and Transplant Cardiology | Indianapolis, IN | 186 | $5.2M |
| 4 | Kimberly Thompson | Nurse Practitioner | New Orleans, LA | 180 | $4.3M |
| 5 | John Swisher | Pulmonary Disease | Knoxville, TN | 143 | $3.3M |
| 6 | Ricardo Restrepo-Jaramillo | Pulmonary Disease | Tampa, FL | 137 | $3.1M |
| 7 | Moises Cossio | Pulmonary Disease | Roanoke, VA | 114 | $2.7M |
| 8 | Linda Cadaret | Advanced Heart Failure and Transplant Cardiology | Iowa City, IA | 100 | $2.4M |
| 9 | Rahul Argula | Pulmonary Disease | Charleston, SC | 89 | $2.2M |
| 10 | Marc Pritzker | Cardiology | Minneapolis, MN | 86 | $2.0M |
| 11 | Murali Chakinala | Pulmonary Disease | Saint Louis, MO | 73 | $2.0M |
| 12 | Saurabh Rajpal | Adult Congenital Heart Disease | Columbus, OH | 81 | $1.9M |
| 13 | Mark Hoffmann | Interventional Cardiology | Wausau, WI | 81 | $1.9M |
| 14 | Hunter Champion | Cardiology | Columbus, GA | 77 | $1.8M |
| 15 | Randolph Rough | Cardiology | West Des Moines, IA | 76 | $1.8M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 109 | Alirocumab (Praluent Pen) | $165.6M | 203,805 |
| 110 | Pantoprazole Sodium (Pantoprazole Sodium) | $165.1M | 10,061,854 |
| 111 | Lenvatinib Mesylate (Lenvima) | $164.6M | 7,004 |
| 112 | Treprostinil (Tyvaso Dpi) | $158.9M | 6,704 |
| 113 | Rimegepant Sulfate (Nurtec Odt) | $155.0M | 106,692 |
| 114 | Teriparatide (Forteo) | $153.9M | 38,259 |
| 115 | Ixekizumab (Taltz Autoinjector) | $149.8M | 19,972 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology